Numinus Wellness Inc.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
16.0M
P/E Ratio
-
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through Clinical Research Operations and Practitioner Training segments. It also provides clinical research management services to academic institutions and biotechnology companies. In addition, the company engages in the provision of education and training for research and drug development organizations to support clinical trials and commercialization efforts. Numinus Wellness Inc. is headquartered in Vancouver, Canada.
Healthcare
Medical Care Facilities
TSX
Key Financial Metrics
4.2M
Revenue
-19.6M
Net Income
C$-0.07
EPS (Diluted)
-17.5M
Free Cash Flow
Profitability
Gross Margin
28.0%
Operating Margin
-280.9%
Net Profit Margin
-471.2%
EBITDA
-13.9M
Returns & Efficiency
Return on Assets (ROA)
-182.3%
Return on Equity (ROE)
-2707.8%
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
10.8M
Total Debt
2.0M
Debt to Equity
2.80x
Current Ratio
1.14
Company Info
| Industry | Medical Care Facilities |
| HQ | Vancouver, Canada |
| Fiscal Year End | 1725062400 |
| Currency | CAD |
| Website | www.numinusnetwork.com |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
208,000
Shares Sold
0
Total Transactions
1
SEDAR+ Filings
View All Filings9
Annual Reports
14
Quarterly Reports
23
MD&A
99
News Releases
5
Material Changes
3
Prospectuses
8
Governance
48
Certifications
51
Other
●
2025-09-03
●
2024-11-18
●
2024-05-13
●
2021-12-21
●
2020-12-08
●
2023-09-25
●
2020-12-21
●
2020-12-11
Interactive Charts
Company Profile
General Information
| Company Name | Numinus Wellness Inc. |
| Ticker | NUMI.TO |
| Exchange | TSX |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Headquarters | Vancouver, Canada |
| Fiscal Year End | 1725062400 |
| Currency | CAD |
| Website | www.numinusnetwork.com |
Financial Summary
| Market Cap | 16.0M |
| Revenue | 4.2M |
| Net Income | -19.6M |
| P/E Ratio | N/A |
| EPS (Diluted) | C$-0.07 |
| Net Margin | -471.2% |
| ROE | -2707.8% |
| Dividend Yield | N/A |
Business Description
Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through Clinical Research Operations and Practitioner Training segments. It also provides clinical research management services to academic institutions and biotechnology companies. In addition, the company engages in the provision of education and training for research and drug development organizations to support clinical trials and commercialization efforts. Numinus Wellness Inc. is headquartered in Vancouver, Canada.